Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial. - Lancet - X-MOL
Banking on African Infrastructure - Ibrahim Mayaki
39217 PDFs and publications in INNOVATION PROCESS
Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial. - Lancet - X-MOL